Endo International (ENDP) Tops Q4 EPS by 17c, Revenues Beat; Provides FY20 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
Go back to Endo International (ENDP) Tops Q4 EPS by 17c, Revenues Beat; Provides FY20 EPS/Revenue Outlook
February 26, 2020 12:45 PM EST
Cowen analyst Ken Cacciatore raised the price target on Endo International plc (NASDAQ: ENDP) to $5.00 (from $4.00) while maintaining a Market Perform rating.
The analyst commented, "We maintain our thesis and would find better alternatives. The current leverage combined with the still undefined opioid... More
February 25, 2020 12:29 PM EST
RBC analyst Randall Stanicky said Mallinckrodt's (NYSE: MNK) proposed global opioid settlement an incremental positive for others that have opioid litgation exposure, including Allergan (NYSE: AGN), Amneal Pharmaceuticals (NYSE: AMRX), Endo International... More
February 25, 2020 9:21 AM EST
Today's Pre-Open Stock Movers
Mallinckrodt Plc (NYSE: MNK) 38.2% HIGHER; its specialty generic unit will file for bankruptcy protection as it agreed to settle opioid-related cases globally by paying $1.6 billion over eight years.
Tupperware Brands (NYSE: TUP)... More
February 25, 2020 8:22 AM EST
Teva (NYSE: TEVA), Endo (NASDAQ: ENDP) Trade Higher in Sympathy with Mallinckrodt (NYSE: MNK) Following Opioid Settlement Agreement
...
More
February 24, 2020 2:40 PM EST
Weakness in Teva Pharma (NYSE: TEVA) and Endo International (NASDAQ: ENDP) Monday afternoon was said to be tied in part to rumors peer Mallinckrodt (NYSE: MNK) is in creditor talks ahead of a potential bankruptcy of its U.S. generics business.
...
More
